← Browse by Condition
Medical Condition
eosinophilic esophagitis
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 3, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for eosinophilic esophagitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — eosinophilic esophagitis Clinical Trials
How many clinical trials are currently recruiting for eosinophilic esophagitis?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for eosinophilic esophagitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for eosinophilic esophagitis?
eosinophilic esophagitis research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a eosinophilic esophagitis clinical trial?
Eligibility criteria for eosinophilic esophagitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06596252 Phase 3
Recruiting
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Enrollment
308 pts
Location
United States, Spain
Sponsor
Dr. Falk Pharma GmbH
NCT04506593
Recruiting
Indiana University Gastrointestinal Motility Diagnosis Registry
Enrollment
5,000 pts
Location
United States
Sponsor
Indiana University
NCT02504853
Recruiting
Natural History and Genetics of Food Allergy and Related Conditions
Enrollment
1,800 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06381219
Recruiting
Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial
Enrollment
36 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT05199532
Recruiting
Eosinophilic Gastrointestinal Disorders Registry
Enrollment
500 pts
Location
United States
Sponsor
Ann & Robert H Lurie Children'...
NCT05608681 Phase 1, Phase 2
Recruiting
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Enrollment
117 pts
Location
Australia, Canada, N...
Sponsor
Eupraxia Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology